Ampliphi Biosciences Corp (NYSEAMERICAN:APHB) saw unusually-high trading volume on Tuesday . Approximately 4,942,300 shares were traded during trading, an increase of 116% from the previous session’s volume of 2,287,360 shares.The stock last traded at $1.87 and had previously closed at $1.37.
Separately, HC Wainwright set a $5.00 target price on shares of Ampliphi Biosciences and gave the company a “buy” rating in a report on Wednesday, November 15th.
The company has a market capitalization of $13.01, a price-to-earnings ratio of -0.15 and a beta of 2.93.
About Ampliphi Biosciences
AmpliPhi Biosciences Corporation is a biotechnology company. The Company is focused on the discovery, development and commercialization of phage therapeutics. The Company is engaged in identifying, characterizing and developing naturally occurring bacteriophages with its collaboration partners in bacteriophage biology, synthetic biology and manufacturing, to develop second-generation bacteriophage products.
Receive News & Ratings for Ampliphi Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampliphi Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.